- Q1 2024 NN Inc Earnings Call TranscriptMay 07, 2024$3.42 (-10.00%)Earnings
- Q4 2023 NN Inc Earnings Call TranscriptMar 12, 2024$4.16 (-17.95%)Earnings
- Q3 2023 NN Inc Earnings Call TranscriptNov 07, 2023$2.01 (+0.50%)Earnings
- Q2 2023 NN Inc Earnings Call TranscriptAug 04, 2023$2.75 (-7.72%)Earnings
- Q1 2023 NN Inc Earnings Call TranscriptMay 05, 2023$1.02 (-5.56%)Earnings
- Q4 2022 NN Inc Earnings Call TranscriptMar 10, 2023$1.41 (-12.42%)Earnings
- Q3 2022 NN Inc Earnings Call TranscriptNov 02, 2022$2.09 (-17.88%)Earnings
- Q2 2022 NN Inc Earnings Call TranscriptAug 05, 2022$2.46 (-12.14%)Earnings
- NN Inc Host Virtual Investor Day TranscriptMay 20, 2022
- Q1 2022 NN Inc Earnings Call TranscriptMay 06, 2022$3.15 (+1.61%)Earnings
- Q4 2021 NN Inc Earnings Call TranscriptMar 11, 2022$2.88 (+10.34%)Earnings
- Q3 2021 NN Inc Earnings Call TranscriptNov 05, 2021$5.69 (+4.02%)Earnings
- Q2 2021 NN Inc Earnings Call TranscriptAug 06, 2021$6.61 (-5.97%)Earnings
- Q1 2021 NN Inc Earnings Call TranscriptMay 07, 2021$7.54 (+6.80%)Earnings
- NN Inc Today Announced That It Will Host An Investor Update Corporate Call TranscriptApr 07, 2021
- Q4 2020 NN Inc Earnings Call TranscriptMar 12, 2021$7.82 (+10.14%)Earnings
- Q3 2020 NN Inc Earnings Call TranscriptNov 06, 2020$5.65 (-5.20%)Earnings
- NN Inc Sale of Life Sciences division to American Securities LLC - M&A Call TranscriptAug 24, 2020
- Q2 2020 NN Inc Earnings Call TranscriptAug 07, 2020$6.13 (+7.73%)Earnings
- Q1 2020 NN Inc Earnings Call TranscriptMay 08, 2020$2.75 (+0.73%)Earnings
- Q4 2019 NN Inc Earnings Call TranscriptMar 13, 2020$4.01 (-4.75%)Earnings
- Q3 2019 NN Inc Earnings Call TranscriptNov 08, 2019$8.78 (+14.17%)Earnings
- Q2 2019 NN Inc Earnings Call TranscriptAug 09, 2019$6.76 (+8.33%)Earnings
- Q1 2019 NN Inc Earnings Call TranscriptMay 10, 2019$9.09 (+0.89%)Earnings
- Q4 2018 NN Inc Earnings Call TranscriptMar 14, 2019$7.93 (-12.38%)Earnings
NN Inc Sale of Life Sciences division to American Securities LLC - M&A Call Transcript
Good morning, and welcome to the NN Inc. investor presentation regarding divestiture of its Life Sciences division. Today's call is being recorded. I will now hand the call over to Mr. Mark Schuermann. Please go ahead, sir.
Thank you, operator. Good morning, everyone, and thank you for joining us. I'm Mark Schuermann, Vice President, Treasurer, Investor Relations. I'd like to welcome you to attending today's business update. Our presenters this morning will be President and Chief Executive Officer, Warren Veltman; and Tom DeByle, Senior Vice President and Chief Financial Officer. If anyone needs a copy of the press release or the supplemental presentation, please contact Abernathy MacGregor at (212) 371-5999.
Before we begin, I'd ask that you take note of the cautionary language regarding forward-looking statements contained in today's press release, supplemental presentation and in the Risk Factors section in the company's annual report on Form 10-K for fiscal year ended December 31, 2019, and the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)